Takayuki Kadoya

Takayuki Kadoya

Auto-generated profile, based on publicly available information

Takayuki Kadoya

Department of Breast Surgery, Hiroshima University Hospital, Hiroshima, Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2013 in Breast Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
TKTakayuki Kadoya
Takayuki Kadoya
KAKenjiro Aogi
Kenjiro Aogi
SKSachiko Kiyoto
Sachiko Kiyoto
NMNorio Masumoto
Norio Masumoto
YSYoshifumi Sugawara
Yoshifumi Sugawara
MOMorihito Okada
Morihito Okada
The malignant biological behavior of breast cancer remains obscure on diagnostic images, although understanding the grade of such malignancy is important for selecting appropriate treatment. Therefore, malignancy grades in operable breast cancer were evaluated using positron emission tomography/computed tomography (PET/CT) in a multicenter setting. We prospectively examined the features and prognosis of 344 patients (mean age ± SD: 58.0 ± 12.5 years) with clinical stages I–III breast cancer, who underwent surgical intervention without induction therapy between January 2006 and December 2011. Maximum standardized uptake values (maxSUV) obtained from whole-body fluorodeoxyglucose-PET/CT immediately before surgery were assessed to predict the malignant aggressiveness of tumors including the recurrence-free survival of the patients. Variations in maxSUV among institutions, which are limitations of PET assessments in multicenter studies, were adjusted using a phantom study. The median follow up period was 52 months. The patients were divided into groups according to cut-off maxSUV (≤3.0 vs. >3.0) values established from receiver operating characteristic analysis of recurrence (area under the curve = 0.713). A higher maxSUV was significantly associated with a higher T-factor (p < 0.0001), N-factor (p = 0.0049), nuclear grade (p < 0.0001), negative for estrogen (p = 0.0309), and progesterone receptors (p = 0.0063), positive for human epidermal growth factor receptor 2 (p = 0.0012), lymph node metastasis (p = 0.0128), and vascular invasion (p = 0.0110). Multivariate analysis using Cox proportional hazard regression model revealed high maxSUV and negative estrogen receptor status as significantly prognostic factors (p = 0.033 and p = 0.004, respectively). This study demonstrated that maxSUV on PET/CT as well as estrogen receptor status is useful to predict malignancy grades and the prognosis of patients with breast cancer.

25 March 2020 in Cancer Science
Verified
Journal Article
Open access
PDF file
YKYumiko Koi
Yumiko Koi
Yasuhiro TsutaniYasuhiro Tsutani
Yasuhiro Tsutani
YNYukie Nishiyama
Yukie Nishiyama
DUDaisuke Ueda
Daisuke Ueda
YIYuta Ibuki
Yuta Ibuki
Hidetoshi TaharaHidetoshi Tahara
Hidetoshi Tahara
Emerging evidence indicates that small RNAs, including microRNAs (miRNAs) and their isoforms (isomiRs), and transfer RNA fragments (tRFs), are differently expressed in breast cancer (BC) and can be detected in blood circulation. Circulating small RNAs and small RNAs in extracellular vesicles (EVs) have emerged as ideal markers in small RNA‐based applications for cancer detection. In this study, we first undertook small RNA sequencing to assess the expression of circulating small RNAs in the serum of BC patients and cancer‐free individuals (controls). Expression of 3 small RNAs, namely isomiR of miR‐21‐5p (3′ addition C), miR‐23a‐3p and tRF‐Lys (TTT), was significantly higher in BC samples and was validated by small RNA sequencing in an independent cohort. Our constructed model using 3 small RNAs showed high diagnostic accuracy with an area under the receiver operating characteristic curve of 0.92 and discriminated early‐stage BCs at stage 0 from control. To test the possibility that these small RNAs are released from cancer cells, we next examined EVs from the serum of BC patients and controls. Two of the 3 candidate small RNAs were identified, and shown to be abundant in EVs of BC patients. Interestingly, these 2 small RNAs are also more abundantly detected in culture media of breast cancer cell lines (MCF‐7 and MDA‐MB‐231). The same tendency in selective elevation seen in total serum, serum EV, and EV derived from cell culture media could indicate the efficiency of this model using total serum of patients. These findings indicate that small RNAs serve as significant biomarkers for BC detection.

19 April 2022 in Discover Oncology
Verified
Journal Article
Open access
PDF file
NGNoriko Goda
Noriko Goda
SSShinsuke Sasada
Shinsuke Sasada
HSHideo Shigematsu
Hideo Shigematsu
NMNorio Masumoto
Norio Masumoto
KAKoji Arihiro
Koji Arihiro
TKTakayuki Kadoya
Takayuki Kadoya
Purpose: FOXP3 + and CD8 + are recognized markers of tumor-infiltrating lymphocytes (TILs) for breast cancer. FOXP3 + TILs are composed of effector Tregs (eTregs) and other subpopulations that are classified by their differences in suppressive function. In this prospective study, we evaluated Treg subpopulations and CD8 + TILs in breast cancer.Methods: 84 patients with breast cancer were enrolled. Fresh TILs were extracted andTregs were classified into eTregs (CD4+FOXP3highCD45RA−), other FOXP3+Treg subsets (naïve and non-Tregs), and total CD8+CD4−TILs using flow cytometry. The suppression strength of each Treg subpopulation was analyzed. The association between TIL subpopulations, clinicopathological characteristics, and response to chemotherapy was evaluated.Results: The mean CD8/eTreg ratio value was 7.86 (interquartile range: 4.08–12.80). The proliferation function of eTregs was significantly suppressed compared with that of the other subpopulations (proliferation rates: control: 89.3%, + naiiveTreg: 64.2%, + non-Treg: 78.2% vs eTreg 1.93%; all P < 0.05). The patients with high with a high CD8 + /eTreg ratio achieved excellent pathological complete response (pCR) rate of neoadjuvant chemotherapy (90.2%) and the CD8/eTreg ratio were independent predictive factors for pCR (odds ratio:18.7(confidence interval 1.25–279) P < 0.05). A detailed assessment of the CD8/eTreg ratio for each patient who underwent NAC revealed that high CD8/eTreg ratio showed a significantly higher pCR rate compared to patients with a low CD8/FOXP3 ratio (39.6% vs 13.3, P < 0.05) in triple negative subtype patients with stromal TILs < 50%.Conclusions: A high CD8/eTreg ratio enhances pCR rate in patients with invasive breast cancer.

24 June 2020 in IEEE Transactions on Instrumentation and Measurement
Verified
Journal Article
Closed access
HSHang Song
Hang Song
SSShinsuke Sasada
Shinsuke Sasada
NMNorio Masumoto
Norio Masumoto
TKTakayuki Kadoya
Takayuki Kadoya
MOMorihito Okada
Morihito Okada
TKTakamaro Kikkawa
Takamaro Kikkawa
Radar-based microwave imaging is a promising technique for multiple medical applications such as breast health monitoring, breast cancer detection, ablation monitoring, and chemotherapy monitoring. In our previous work, a hand-held multistatic CMOS impulse-radar detector was developed. It was designed to be placed directly on the patient in supine position without a coupling medium. In the radar-based microwave breast imaging, the surface clutters, which are generated from skin reflection, imperfect contacts and antenna coupling, deteriorate the imaging quality. This paper proposes a two-stage rotational (TSR) clutter suppression method for the multistatic rotational configuration of the radar-detector. It consists of a signal selection stage and an adaptive filtering stage. The novelty of the proposed method is that a prior constraint using L2 regularization is introduced to facilitate the filtering. Meanwhile, the antenna and channel variations are considered in the signal selection. The performance of the proposed method is verified in experiments with different surface conditions and patient trial. The results demonstrated that the proposed method is effective in suppressing the surface clutters and improving the image quality.

17 December 2018 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
HSHang Song
Hang Song
SSShinsuke Sasada
Shinsuke Sasada
NMNorio Masumoto
Norio Masumoto
TKTakayuki Kadoya
Takayuki Kadoya
NSNoriyuki Shiroma
Noriyuki Shiroma
TKTakamaro Kikkawa
Takamaro Kikkawa
The objective of this study is to investigate the detectability of breast tumors having various histological types in excised breast tissues of total mastectomy. The tumor images measured by a portable impulse-radio-ultra-wideband (IR-UWB)-radar-based breast cancer detector are compared with both pathological images and images of dedicated breast positron emission tomography (DbPET). It is found that the detector can detect invasive-ductal-carcinomas (IDC) and extensive intra-ductal component (EIC) in the dense breast. The density of the breast has correlation to the effective permittivity derived from the reconstructed confocal images. The results show that the IR-UWB-radar-based breast cancer detector has a potential as a portable modality for early-stage breast cancer screening.

20 April 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
YKYoshie Kobayashi
Yoshie Kobayashi
TKTakayuki Kadoya
Takayuki Kadoya
AAAi Amioka
Ai Amioka
HHHideaki Hanaki
Hideaki Hanaki
SSShinsuke Sasada
Shinsuke Sasada
MOMorihito Okada
Morihito Okada
Wnt5a-induced cell migration is associated with the aggressiveness of estrogen receptor-positive breast cancer Wnt5a-induced cell migration is associated with the aggressiveness of estrogen receptor-positive breast cancer